Navigation Links
New On the Menu: Genetically Modified Salmon?
Date:9/13/2010

By Jenifer Goodwin
HealthDay Reporter

FRIDAY, Sept. 10 (HealthDay News) -- The U.S. Food and Drug Administration may soon approve genetically modified salmon for humans to eat, a prospect that is raising concern among some consumer advocates who consider the fish a threat to both health and the environment.

On Sept. 3, a scientific panel of experts that advises the FDA paved the way for the approval of genetically modified salmon, calling it "as safe as food from conventional Atlantic salmon."

The FDA's Veterinary Medicine Advisory Committee went on to say that the fish -- AquAdvantage Salmon developed by Waltham, Mass.-based AquaBounty Technologies -- contained the same amount of nutrients and had "no biologically relevant differences" from ordinary farmed Atlantic salmon. The FDA is scheduled to hold public hearings on the issue from Sept. 19 to 21.

If AquaBounty's salmon is approved, it would mark the first time a genetically modified animal has been approved for America's dinner plates and restaurant menus.

That's what worries consumer advocates, who say approving the salmon is opening the door to all sorts of genetically engineered animals, such as pigs and other mammals.

The FDA is regulating genetically engineered animals as it would a new veterinary drug, which means that much of the research and information about the product is being kept confidential, said Wenonah Hauter, executive director of Food & Water Watch in Washington, D.C.

"We don't know if it's safe for humans to eat and the only research that has been done was done by the company," according to Hauter. "The FDA is an under-resourced agency that has had so much trouble with the regulatory system for foods -- we've had tainted eggs, poisonous peanuts and other contaminations -- and is now taking on something in a very non-transparent way."

Recently, Food & Water Watch was joined by 30 other animal welfare, consumer environmental and fisheries groups, including the Sierra Club, which issued a statement citing concerns that the fish could escape and pose an environmental threat. Previously, another group of consumer advocates and others warned that "transgenic fish" could introduce new or unknown allergens into the food supply.

AquaBounty creates its salmon by taking a growth gene from the Chinook salmon and a gene "promoter" from the ocean pout, another type of fish, said John Buchanan, AquaBounty's director of research and development. The pout gene promoter simply turns on the Chinook salmon growth gene, and is not actually expressed [active] in the modified fish. The resulting salmon grow to market weight about twice as fast as ordinary Atlantic salmon, though they don't get larger overall.

While it typically takes about three years for salmon to grow to market weight, AquaBounty's salmon get there in about 18 months, Buchanan said.

To safeguard the environment, Buchanan said the eggs will be treated so that all fish that grow from them will be sterile females. That means they will not be able to reproduce, nor will they come into contact with males to reproduce with, said Buchanan, whose firm would sell the treated eggs.

While farm-raised salmon is typically grown in ocean-based tanks, the genetically modified fish will be grown in land-based tanks, also minimizing the chances of escape, he said.

"We have done a tremendous amount of work geared toward regulatory approval to show that the fish is healthy and safe," Buchanan said.

Genetically modified animals have been produced since the 1970s, according to background information in the FDA's briefing materials, but none have been approved for human consumption.

Currently, genetically modified soybeans and corn are being sold for people to eat.

AquaBounty said bringing the salmon to market would take at least 18 months after approval. Farmers that want to grow the fish will also need FDA approval of their facilities.

Buchanan also believes that, if approved, the fish could help reduce pollution, disease and other problems associated with saltwater fish farms, as well as provide an alternative source of seafood to help reduce the impact of overfishing.

One question for consumers is whether packaging will be required to specify that the salmon is genetically modified. The FDA will consider that issue during the public hearings.

More information

Read what the U.S. Food and Drug Administration advisory panel had to say about genetically modified salmon.

SOURCES: Wenonah Hauter, Executive Director, Food & Water Watch, Washington. D.C.; John Buchanan, PhD, director, research and development, AquaBounty, San Diego


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fat in Males, Females Differs Genetically, Mouse Study Shows
2. Plant pathogen genetically tailors attacks to each part of host, say Stanford researchers
3. Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show
4. NIH Stem Cell Guidelines Should Be Modified, UCSF Team Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New On the Menu: Genetically Modified Salmon?
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
Breaking Medicine Technology: